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ParamyxovirusMost paramyxoviruses enter the cell by direct fusion of the viral envelope with the plasma membrane. Our pre-
vious studies have shown the colocalization of Newcastle Disease Virus (NDV) with the early endosome marker
EEA1 and the inhibition of NDV fusion by the caveolin-phosphorylating drug phorbol 12-myristate 13-acetate
(PMA) prompted us to propose that NDV enters the cells via endocytosis. Herewe show that the virus-cell fusion
and cell-cell fusion promoted by NDV-F are increased by about 30% after brief exposure to low pH in HeLa and
ELL-0 cells but not in NDV receptor- deﬁcient cell lines such as GM95 or Lec1. After a brief low-pH exposure,
the percentage of NDV fusion at 29 °C was similar to that at 37 °C without acid-pH stimulation, meaning that
acid pHwould decrease the energetic barrier to enhance fusion. Furthermore, preincubation of cells with the pro-
tein kinase C inhibitor bisindolylmaleimide led to the inhibition of about 30% of NDV infectivity, suggesting that a
population of virus enters cells through receptor-mediated endocytosis. Moreover, the involvement of the
GTPase dynamin in NDV entry is shown as its speciﬁc inhibitor, dynasore, also impaired NDV fusion and infectiv-
ity. Optimal infection of the host cellswas signiﬁcantly affected bydrugs that inhibit endosomal acidiﬁcation such
as concanamycin A, monensin and chloroquine. These results support our hypothesis that entry of NDV into ELL-
0 and HeLa cells occurs through the plasmamembrane aswell as by dynamin- low pH- and receptor- dependent
endocytosis.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Newcastle Disease Virus (NDV), a prototype of paramyxovirus, is
an avian enveloped RNA-negative strand virus that causes respiratory
disease in domestic fowl, leading to huge economic losses in the poultry
industry. The envelope of NDV contains two associated glycoproteins
that mediate viral entry: the hemagglutinin-neuraminidase (HN) and
fusion (F) proteins. HN is the receptor-binding protein that recognizes
and binds to sialoglycoconjugates at the cell surface [1] and also has
receptor-cleaving (sialidase) activity [2]. Based on crystallographic
studies of the HN of NDV, two sialic acid-binding sites have been
described [3,4], site II being located at the dimer interface and activated
after engagement of site I to its receptor [4,5]. Site I exhibits both recep-
tor-binding and sialidase activities while site II only has receptor binding
activity [4]. Moreover, the triggering of F protein requires the presence of
its homotypic attachment protein through its fusion promotion activity.
Enveloped viruses enter the cell through two main mechanisms: by
direct fusion of the viral envelope with the plasma membrane or by
endocytosis. The use of the cellular endocytic machinery is commonly
associated with low-pH-dependent activation of viral fusion proteins
such as in inﬂuenza virus or in vesicular stomatitis virus [6].ultiplicity of infection; R18,
usal.es (I. Muñoz-Barroso).
ights reserved.Additionally, the fusion protein of Ebola virus is activated by acidic-
pH-dependent proteases inside endosomes [7]. Moreover, recent stud-
ies suggest that viruses with pH-independent fusion proteins may use
endocytosis for entry (revised in [8]). Different families of viruses may
use several different endocytic routes [9–11], the major pathway being
the clathrin-mediated endocytosis used by viruses such as Semliki For-
est and Sindbis alpha virus [12] or Hantaan virus [13]. Recent reports in-
dicate that HIV also uses this route productively [14]. Caveola-mediated
endocytosis is the second best characterized pathway used by SV40 and
Ebola viruses to enter cells [15–18]. Although most viruses have been
described to enter the cell through a unique mechanism, there are in-
creasing reports showing that many viruses are able to use alternative
uptake pathways to infect different target cells or even simultaneous
entry mechanisms in the same cell type ([8,19] and references therein).
With the exception of the fusion protein of the human
metapneumovirus (HMPV), which depends on low-pH [20], para-
myxovirus fusion proteins are activated at neutral pH, which sug-
gests that viral entry occurs by direct fusion at the plasma
membrane [2]. Nevertheless, recent reports point to the notion
that the pH requirement for fusion does not necessarily imply
the location of membrane fusion (revised in [21,22]). Some
members of the paramyxoviruses such as Sendai, Nipah, human
metapneumovirus and human respiratory syncytial virus (hRSV)
[23–26] utilize the endocytic machinery for entry. Furthermore,
as assessed by a R18 dequenching assay, our previous studies
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[27] and the colocalization of NDVwith the early endosomemarker
EEA1 [28]. These ﬁndings prompted us to suggest that the entry
of NDV would occur through caveola-mediated endocytosis as an
additional mechanism to direct fusion with the plasma membrane
[28]. To gain further insight into the molecular mechanisms of NDV
entry, the present study focuses on the characterization of the NDV
entry mechanism through the use of low-pH treatment of several
cell lines that differ in the expression of sialoglycoconjugates at
their surface and by analyzing the effect of different substances
that either interfere with endocytosis or endosomal acidiﬁcation
on NDV interaction with cells. NDV entry showed to be sensitive
to endosomal acid pH, and dynamin and protein kinase C inhibitors
blocked NDV fusion and infectivity. Our data support the idea that
NDV may penetrate HeLa and ELL-0 cells both by direct fusion
at the cell surface and through receptor-mediated and dynamin-
dependent endocytosis, at least in these cell lines.
2. Materials and methods
2.1. Cell lines and viruses
East Lansing Line (ELL-0) avian ﬁbroblasts and HeLa cells were
obtained from the American Type Culture Collection (ATCC); MEB4
and GM95 were obtained from Riken BRC Cell Bank (Tsukuba, Japan);
ELL-0, HeLa, MEB4 andGM95 cells weremaintained in Dulbecco's mod-
iﬁed Eagle's medium (DMEM); Chinese hamster ovary (CHO) and mu-
tant Lec1 were also purchased from ATCC and maintained in DMEM:
F12 and AlphaMEM media respectively. All media were supplemented
with L-GlutaMax (580 mg l−1, Invitrogen), penicillin–streptomycin
(100 U ml−1–100 μg ml−1) and 10% heat-inactivated fetal bovine
serum (complete medium). The lentogenic “Clone 30” strain of NDV
was obtained from Intervet Laboratories (Salamanca, Spain). The virus
was grown and puriﬁed mainly as described previously [28]. For in-
ectivity assays, a recombinant NDV derived from the Hitchner B1
lentogenic strain (rNDV-F3aa-mRFP [29]), which expresses a mono-
meric red-ﬂuorescent protein [30] and kindly provided by Dr. Adolfo
García-Sastre, was used.
2.2. Reagents and antibodies
Bisindolylmaleimide I (BIM) was from Calbiochem; dynasore,
concanamycin A, monensin, chloroquine, protease inhibitor cocktail
and proteinase K were from Sigma Chemical Co; octadecylrhodamine B
chloride (R18), Hoechst 33258, calcein, lipofectamine and Alexa Fluor
488 donkey anti-mouse antibody were from Molecular Probes. Mono-
clonal anti-NP and polyclonal anti-NDV antibodies were generous gifts
fromDr. García-Sastre (Emerging Pathogens Institute,Mount Sinai School
of Medicine, New York, USA); monoclonal anti-HN 14f and 1b antibodies
were kindly provided by Dr. M. Iorio (University of Massachusetts
Medical School, Worcester, USA).
2.3. Virus titration
Virus titers were calculated in plaque-formation assays in Vero
cells, as described [31]. Plaque numbers were counted under a light
microscope and NDV infectivity was expressed as plaque-forming
units (pfu) ml−1.
2.4. Virus-binding assays
Monolayers of HeLa, ELL-0, MEB4, GM95, CHO and Lec1 cells on
35 mm plates were previously treated with the different inhibitors
and then incubated with NDV at a moi of 1 for 1 h at 4 °C in the contin-
uous presence of the inhibitor. Cells were washed with ice-cold PBS to
remove unbound virus and then collected from the plates by incubationwith EDTA (520 μM) at 37 °C. Cells were pelleted by centrifugation and
ﬁxed with 2.5% paraformaldehyde for 30 min at 4 °C. After centrifuga-
tion, cells were incubated with anti-HN 14f and 1b mAbs in blocking
solution (dilution 1:100) for 1 h at 4 °C. Then, the cellswere centrifuged
and incubated with blocking solution containing anti-mouse Alexa
Fluor 488-conjugated IgG (5 μg ml−1) for 1 h at 4 °C. Cells were then
pelleted by centrifugation and resuspended in a suitable volume of
PBS for analysis in a FACScalibur ﬂow cytometer (Becton Dickinson).
At least 5 × 104 cells were analyzed for each sample. Meanﬂuorescence
values were normalized to the control values. Data were analyzed with
WinMDI 2.9 software.
2.5. NDV–cell fusion assays
Puriﬁed NDVwas labeled with the ﬂuorescent probe R18 essentially
as described previously [32]. Cells plated in 24-well plates treated
or untreated with the inhibitors were incubated for 30 min at 4 °C on
ice with 2 μg of R18-NDV per plate. Then, cells were washed three
times with cold PBS and incubated in complete medium containing
Hoechst 33258 (10 μg ml−1) for 1 h at 37 °C. They were ﬁxed with 2%
formaldehyde in PBS and the transfer of the rhodamine probe to
cells was observed under an Olympus IX51 inverted ﬂuorescence
microscope. The percentage of fusion was calculated as the number of
positive red-stained cells in 10 random ﬁelds with respect to the total
number of cells in these areas of the well.
2.6. NDV infectivity assays
Monolayers of cells were infected for 1 h at room temperature with
different dilutions of the recombinant NDV rNDV-F3aa-mRFP. After
24 h at 37 °C, the cells were observed under an Olympus IX51 inverted
ﬂuorescence microscope with a 10× objective. The percentage of infec-
tivity was calculated as the number of red-ﬂuorescent cells out of the
total number of cells in six random ﬁelds.
2.7. FACS infectivity assays
Monolayers of HeLa, ELL-0, MEB4, GM95, CHO and Lec1 cells on
35 mm plates were treated with the inhibitors and then incubated
with 1 moi of NDV for 1 h at 37 °C in the presence of inhibitor. Cells
were washed with ice-cold PBS to remove unbound virus andwere col-
lected from the plates by incubation with EDTA (520 μM) at 37 °C. Cells
were pelleted by centrifugation and ﬁxed with 2.5% paraformaldehyde
for 30 min at 4 °C. Then, cells were blocked and permeabilized with
PBS containing 1% BSA (blocking solution) and 0.1% TX100 for 20 min
at 4 °C. After centrifugation, cells were incubated with anti-NP mAb in
blocking solution (dilution 1:200) for 1 h at 4 °C. Then, they were cen-
trifuged and incubated with blocking solution containing anti-mouse
Alexa Fluor 488-conjugated IgG (5 μg ml−1) for 1 h at 4 °C. Cells
were then pelleted by centrifugation and resuspended in a suitable
volume of PBS for analysis with a FACScalibur ﬂow cytometer (Becton
Dickinson). At least 5 × 104 cells were analyzed for each sample.
Mean ﬂuorescence values and the % of cells with ﬂuorescence higher
than the background were combined to quantify viral protein expres-
sion and were normalized to the control values. Mean ﬂuorescence
values were normalized to control values. Data were analyzed with
WinMDI 2.9 software.
2.8. Syncytium assays
Monolayers of cells were infectedwith 1moi of NDV for 1 h at 37 °C.
At 7 h post-infection, viral F proteins were activated by digestion with
acetyl trypsin [33]. Then, cells were incubated in complete medium
overnight and stained with Giemsa or crystal violet for syncytium
observation. Representative ﬁelds were captured with an inverted
microscope (Olympus IX51). Quantiﬁcation of syncytiawas accomplished
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Fig. 1. Effect of acidic pH on NDV fusion with different cell lines. R18-–cell complexes were
exposed to a 3 min pulse at pH 7.4- or pH 5.0-buffered PBS at 37 °C. After 1 h at 37 °Cwith
regular medium at neutral pH, fusionwas assessed by the transfer of the R18 red dye to the
cell membrane and was quantiﬁed as detailed in Materials and methods. (A) Microphoto-
graphs from a representative experiment. (B) Data are means ± SD of three independent
experiments. Statistical analysis was performed using the paired t test: ***, p b 0.001, ex-
tremely signiﬁcant.
Table 1
Drugs, effects and treatments of cells.
Drug Effect Treatment of cells
Bisindolylmaleimide I
(20 μM)
Protein kinase C inhibitor
(receptor-mediated
endocytosis)
i) Drug present during 1 h of
infection
ii) Drug present during1 h of
infection and for 24 h post-
infection
iii) Addition of the drug after
infection and present for 24 h
post-infection
Dynasore (80 μM) Dinamin-1 GTPase
activity inhibitor (clathrin
and caveolae mediated
endocytosis)
Preincubation for 30 min;
drug present during infection
and for 2 h post-infection.
Concanamycin A (5 nM) Vacuolar ATPase inhibitor Preincubation for 1 h 30 min;
drug present during infection
and for 4 h post-infection.
Monensin (2.5 μM) Ionophore Preincubation for 1 h 30 min;
drug present during infection
and for 4 h post-infection.
Chloroquine (10 nM) Lysosomotropic agent i) Drug preincubated for 1 h
and then removed
ii) Preincubation for 1 h; drug
present during infection and
for 4 h post-infection.
iii) Addition of the drug at 5 h
post-infection and incubation
for additional 6 h
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three random ﬁelds. Areas were quantiﬁed using the analysis tool in
Adobe Photoshop CS4.
2.9. Low-pH-induced fusion
Cells plated in 24-well plates were incubated for 30 min at 4 °C on
ice with 3 μg of R18-NDV per plate. Then, virus–cell complexes were
exposed brieﬂy to either pH 7.4 or pH 5.0 buffer by treating them
with a 3-min pulse of buffered PBS at 37 °C. After 1 h at 37 °C with
regular medium at neutral pH, the percentage of fusion was calculated
as the number of positive red-stained cells in 10 random ﬁelds with
respect to the total number of cells in these areas of the well.
2.10. Plasmid constructs and transfection
Monolayers of HeLa cells grown in 24-well plateswere cotransfected
with 1 μg of pCAGGS encoding viral F protein and/or with HN or empty
pCAGGS for a total amount of 2 μg of DNA per well. Transfection was
performed using lipofectamine. At 24 h post-transfection, cells were
washed and F protein was activated by digestion with acetyl trypsin,
as described above. Following this, dye-transfer fusion or syncytium
assays were performed.
2.11. Dye-transfer fusion assays
Human erythrocytes (RBCs) were double-labeled with calcein and
octadecylrhodamine B chloride (R18). Brieﬂy, RBCs at 10% hematocrit
in PBS were incubated with 100 μg ml−1 of the aqueous dye calcein
for 1 h at 37 °C in the dark. After extensivewashing, RBCswere collected
by centrifugation and incubated with 25 μl (stock 2 mg ml−1) of the
lipid probe R18 for 30 min at room temperature in the dark, followed
by several washing steps to remove unincorporated dye from labeled
cells. Monolayers of HeLa cells in 24-well plates were transfected as
described above. At 24 h post-transfection, F protein was activated as
described above, and the cells were exposed brieﬂy to either pH 7.4 orpH 5.0 buffer by treating them with a 5 min pulse of buffered PBS at
37 °C. Then, the media were removed and, without washing, cells
were overlaid with dye-hematocrit per well in DMEM. The effector–
target cell complexes were incubated at different temperatures for
1 h. Nuclei were stained by incubation with 10 μg ml−1 of Hoechst
dye. Cells then were washed several times with PBS to remove un-
bound RBCs, and dye transfer was visualized under an inverted ﬂuo-
rescence microscope at a magniﬁcation of 10×. The extent of fusion
was calculated as the percentage of dye-labeled cells in the total
number of nuclei.
2.12. Treatment of cells with chemical inhibitors
Conﬂuent monolayers of cells in 24-well plates were pre-treated for
1.5 h for concanamycin A andmonensin, 1 h for chloroquine, or 30 min
for dynasore, with the inhibitor or vehicle control (control volume equal
to the maximum volume of the drug) at the indicated concentrations
(Table 1). For infectivity assays, infections were carried out such that
on average 40% of the cells would be infected in the control wells.
After 4 h at 37 °C in the presence of a drug or vehicle control (2 h for
the dynasore experiments), the cells were washed and incubated in
regular medium overnight at 37 °C. For the BIM experiments, cells
were infected in the presence of the inhibitor for 1 h at room tempera-
ture and were then incubated 24 h at 37 °C in DMEM with the drug.
2.13. Proteinase protection assays
Proteinase K treatment of cells was carried out as previously
described [34]. Virus was added to cell monolayers at a moi of 25,
virus binding was performed at 4 °C for 1 h, and samples were incu-
bated at 37 °C for different times to allow entry. Cells were treated
with proteinase K (200 μg ml) in OptiMEM supplemented with
1 mM CaCl2 for 1 h at 4 °C. The protease-treated cells were pelleted
and lysed in ice-cold lysis buffer (10 mM Tris–HCl, pH 7.5, 150 mM
303L. Sánchez-Felipe et al. / Biochimica et Biophysica Acta 1838 (2014) 300–309NaCl, 1% NP-40) containing 1 mM phenylmethylsulfonyl ﬂuoride
(PMSF) and a cocktail of protease inhibitors. Viral proteins were
detected by Western blotting using primary rabbit polyclonal anti-
NDV antibodies.2.14. Cell viability assays
Cells were detached and a small quantity of them (200 μl) were
mixed with 300 μl Trypan blue 0.4% (p/v) in PBS and with 300 μl
of PBS. These products were mixed for 5–10 min and then 20 μl was
transferred to a counter chamber and the number of total cells and
stained cells (dead cells) was counted. The percentage of viability was
calculated as the number of viable cells out of total number of cells.0
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Fig. 2. Enhancement of NDV F-promoted cell–cell fusion at acidic pH. (A)Monolayers of HeLa an
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The two-tailed unpaired Student's t-test was used to determine sta-
tistical signiﬁcance between two groups. Probability values of p b 0.001
were considered extremely statistically signiﬁcant, p b 0.01 extremely
signiﬁcant and p b 0.05 statistically signiﬁcant. Statistical analyses
were performedwith the QuickCalcs program from GraphPad software.3. Results and discussion
Most paramyxoviruses enter the host by fusion of their envelope
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Fig. 3. Effect of acidic pH on NDV infectivity. Monolayers of the different cell lines were
infected with rNDV-F3aa-mRFP at a moi of 10 (except on HeLa cells, at a moi of 1) for 1 h
at room temperature. Then, cells were treated with three pulses (3 min each) of pH 5.0- or
pH 7.4-buffered PBS with 1 h interval between each pulse. Infectivity was analyzed at 24 h
post-infection by calculating the percentage of red-ﬂuorescent cells (infected cells) out of
the total number of cells in three random ﬁelds. (A)Microphotographs from a representative
experiment. (B)Data aremeans ± SDof three independent experiments. **, p b 0.01, highly
statistically signiﬁcant; ***, p b 0.001, extremely signiﬁcant.
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analyzed NDV fusionwith different cell lines after a short pulse of acidic
pH, as detailed in Materials and methods. The different target cell lines
vary in their surface glycoconjugate expression, i.e., the NDV receptor:
HeLa, which are human epithelial cells commonly used in studies of
many viruses includedNDV; ELL-0, a chicken ﬁbroblast from the natural
host of NDV; GM95, a glycosphingolipid-deﬁcient cell line and its paren-
tal cell line MEB4 [35]; CHO and their mutant Lec1 cells, deﬁcient in
complex N-linked glycosylation but not in glycosphingolipids or
O-glycoproteins [36]. To analyze virus–cell fusion, R18-NDV was
allowed to bind to cells for 30 min at 4 °C, after which virus–cell
complexes were exposed brieﬂy to either pH 7.4 or pH 5.0 buffer
by treatment with a 3 min pulse of buffered PBS. After 1 h at
37 °C with regular medium at neutral pH, the percentage of fusion
was calculated as the number of positive red-stained cells from the
total number of cells.
The data summarized in Fig. 1 show that low pH pulse led to an
increase of about 30% of fusion in two of the cell lines, HeLa and ELL-0,
suggesting that this enhancement might be cell type-speciﬁc, as we
will discuss later. Next, we wished to determine whether syncytium
formation was also stimulated by exposure to low pH in both virus-
infected and HN/F transfected cells. HeLa and ELL-0 cells were infected
with NDV at a moi of 1 for 1 h at 37 °C. Then, cells were treated with
three pulses (3 min each) of pH 5.0- or pH 7.4-buffered PBS, with 1 h
interval between each pulse. At 24 h post-infection syncytiawere quan-
tiﬁed (Fig. 2A). As expected, syncytium formation was enhanced about
2 times as compared with the control in both cell lines. These data cor-
relate with the enhancement of viral infectivity observed after infection
with the recombinant NDV rNDV-F3aa-mRFP (Fig. 3), as discussed later.
Additionally, to determine whether HN protein was essential for fusion
after acidic pH treatment, HeLa cells were transfected with F and/or HN
vectors; at 24 h post-transfection, cells were treated with three low-pH
pulses, as above.When the cells were cotransfected with both F and HN
plasmids, syncytium formation was increased 3.5 times after low-pH
exposure (Fig. 2B) in comparisonwith the controls; acidic pH treatment
increased both the number and the size of the syncytia (micrograph in
Fig. 2B). Nevertheless, NDV F protein did not promote the formation of
syncytia in the absence of HN when treated with low pH (Fig. 2B).
To analyze the effect of acidic pH exposure on NDV infectivity, ELL-0,
HeLa, MEB4, GM95, CHO and Lec1 were infected with the recombinant
NDV rNDV-F3aa-mRFP for 1 h at room temperature at a moi of 10,
except in HeLa cells, which were infected at a moi of 1 because HeLa
cells became fully infected at a moi of 10 (data not shown). Then, cells
were treated with three pulses (3 min each) of pH 5.0- or pH 7.4-
buffered PBS with a 1 h interval. As detailed in Materials and
methods, infectivity was monitored at 24 h post-infection, calculat-
ing the percentage of the red-ﬂuorescent infected cells from the
total number of cells. The results are summarized in Fig. 3 and
Supplementary Fig. S1. Similar to fusion (Fig. 1), the low-pH treat-
ment induced an enhanced infectivity exclusively in ELL-0 and
HeLa cells, again supporting the idea that there are differences in
the entry mechanisms that depend on the cell line.
In the next series of experiments, we analyzed whether the acidic
pH treatment was able to lower the temperature required for NDV F
protein-induced fusion. In order to determine whether the possible
effect was exerted differently in the fusion cascade, we used the dye-
transfer-based fusion assay detailed in Materials and methods. HN-
and F-transfected cells were allowed to fuse with RBCs doubly labeled
with the red probe R18 in their membrane and the green probe calcein
in the cytoplasm. After proteolytic activation of F protein, cellswere treat-
ed with a pulse of acidic or neutral pH (control) for 5 min at 37 °C. Then,
ﬂuorescence-labeled erythrocyteswere added and allowed to fuse for 1 h
at 25 °C, 29 °C, 31 °C or 37 °C. As shown in Fig. 4, fusion did not occur at
25 °C either at neutral pH or after low-pH treatment, although we did
observe an increase in RBCs binding to transfected cells at acidic pH at
this temperature (Fig. 4A, R18 panel, and Supplementary Fig. S2), whichmight contribute to the enhancement of fusion at fusion-permissive
temperatures. Nevertheless, at the suboptimum temperatures of 29 °C
and 31 °C, the extent of fusion after treatment at pH 5.0 was similar
to that of fusion at 37 °C at neutral pH. Finally, as seen in Fig. 2, after
low-pH treatment fusion was increased about 2-fold at 37 °C. In all
cases, transfer of the two probes – R18 and calcein – was similar,
indicating that the enhancement of fusion due to the pulse of
acidic pH had a similar effect on hemifusion (transfer of R18 from
the membrane of the erythrocytes to the membrane of the cell)
and on complete fusion (transfer of calcein from the cytoplasm of
the erythrocyte to the cytoplasm of the cell). As mentioned above,
these data support the hypothesis that acid pH would decrease
the energetic barrier needed for protein activation prior to the
triggering of fusion, although this hypothetical decrease was not
enough to allow fusion at 25 °C. Therefore, acidic pH might increase
the number of F proteins that undergo the conformational changes
leading to membrane fusion, even though the presence of HN protein
would still be required.
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pH reported above (Figs. 1–3) is in agreement with our previous results
[27,28] and strongly supports a role for low pH in NDV entry and the
notion that a certain percentage of NDVmay enter cells by endocytosis,
at least in certain cell lines such as HeLa, ELL-0 and Cos-7. Since in
the course of an infection a viruswould encounter low pH after endocy-
tosis and trafﬁcking through the endocytic pathway, we wanted to fur-
ther explore the possible endocytic entry of NDV studying the effect
of different substances that interfere either with endocytosis or
endosomal acidiﬁcation (Table 1). First, we incubated the target
cells in the presence of bisindolylmaleimide I (BIM), a highly selec-
tive, cell-permeable, and reversible protein kinase C (PKC) inhibitor
[37,38]. In most of the cells, cell viability as assayed by a Trypan blue
exclusion method was higher than 90%, except in GM95, where
a strong cytopathic effect of the drug was observed (about 60%
of cell death, data not shown). We analyzed the effect of BIM
preincubation on NDV infectivity under three different conditions:
i) drug was present during infection and then withdrawn from the
culture medium (Virus + BIM); ii) drug present for the duration
of the assays, i.e., during infection and for 24 h post-infection
(Virus + BIM/BIM); and iii) drug was added at 1 h post-infectionA
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Fig. 4. Effect of acidic pH on the temperature dependence of NDV F-promoted cell–cell fusion. R
acetyl trypsin and cells were treated with pH 5.0- or pH 7.4-buffered PBS for 5 min at 37 °C. Th
1 h. After washing unbound RBC, the extent of dye transfer was analyzed and quantiﬁed as the
Data concerning R18 transfer are shown and are similar to those of calcein transfer (not shown)
three independent experiments. Statistical analyses were performed using the paired t test: * p(Virus/BIM). The data are summarized in Fig. 5; since BIM per se
is a compound that exhibits red ﬂuorescence, the background
(Fig. 5A, BIM) was subtracted from the red ﬂuorescence due to the
mRFP expression occurring after rNDV-F3aa-mRFP infection. The in-
hibitory effect of BIM was not observed when the drug was added
post-infection, meaning that it must act during an early stage of
the infection. The data concerning inhibition (approximately 26%
of inhibition as compared with the control) correlated well with
the observed enhancement of viral fusion in both cell lines after
the low-pH exposure shown in Fig. 3. The infectivity of NDV in
GM95-treated cells was also reduced after BIM treatment, but the
observed reduction could have been be due to the negative effect
of the drug on cell viability. According to our results, NDV could
penetrate in HeLa and ELL-0 cells through receptor-mediated endo-
cytosis, since the inhibition of PKC reduced NDV infectivity by 30% in
comparison with the control (Fig. 5). Similarly, the activity of PKC is
essential for the entry of different non-enveloped [39] or enveloped
viruses, such as inﬂuenza virus [38], alphavirus, rhabdovirus, poxvi-
rus and herpes virus [40], which has been related to the entry
through receptor-mediated endocytosis. Furthermore, we have pre-
viously suggested that caveolae/rafts could be a possible platform31°C 37°C
*
**
pH 7.4
pH 5.0
rature
BCs were double–NDV vectors. At 24 h post-transfection, F0 precursor was activated with
en, cells were incubated with labeled RBC (0.2% hematocrit) at different temperatures for
percentage of red- (R18) or green- (calcein) stained cells out of the total number of cells.
. (A) Microphotographs from a representative experiment. (B) Results are means ± SD of
b 0.05 statistically signiﬁcant: ** p b 0.01 very signiﬁcant.
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locations for PKC [42,43].
We also analyzed the effect of dynasore, a drug that inhibits the
GTPase activity of dynamin 1, which has been implicated in clathrin-
and caveola-mediated endocytosis [44]. Owing to the high toxicity of
this drug in MEB4, GM95, CHO and Lec1 cells, these experiments were
only performed in HeLa and ELL-0 cells, in which cell viability was
higher than 95% after dynasore treatment (data not shown). The fusion
of NDV with treated-HeLa and ELL-0 cells was almost completely abro-
gated (Fig. 6A), as was infectivity, when assayed both by ﬂuorescence
microscopy after rNDV-F3aa-mRFP infection (Fig. 6B) and by FACS
(Fig. 6C). Nevertheless, the binding of NDV to drug-treated cells was
not modiﬁed (data not shown). However, the addition of dynasore at
10 min post-infection resulted in only a minor decrease in infection,
with no effect if added at 20 min post-infection (Fig. 6D), implying that
the main role of dynamin was exerted during the early infection steps
and again supporting a role of endocytosis in NDV entry. The rate of fu-
sion and infectivity inhibition exerted by dynasore (more than 80%)0
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Fig. 5. Effect of PKC inhibition on NDV infectivity. Monolayers of cells were treated with
the PKC-inhibitor BIM at different times of the infectivity experiments. Cells were infected
with rNDV-F3aa-mRFP at a moi of 10 (1 moi for HeLa cells) for 1 h at room temperature
and infectivity was analyzed at 24 h post-infection by calculating the percentage of red-
ﬂuorescent cells (infected cells) out of the total number of cells in six random ﬁelds.
Control, cells without the drug; Virus + BIM: cells were infected in the presence of the
drug and the drug was withdrawn after infection; Virus + BIM/BIM: cells were infected
in the presence of the drug that was also present for the duration of the assays; Virus/
BIM: untreated cells were infected and the drug was added 1 h post-infection; BIM: non-
infected cells in the presence of the drug. (A)Microphotographs froma representative exper-
iment. (B) Data are means ± SD of three independent experiments. **, p b 0.01, highly sta-
tistically signiﬁcant; ***, p b 0.001, extremely signiﬁcant.was higher than that of BIM (Fig. 5) and than the observed enhancement
of NDV fusion and infectivity after low-pH exposure (Figs. 1–4).
Dynamin is essential not only for the ﬁssion of endocytic vesicles in the
endocytic pathways but also for membrane fusion [45], being involved
in fusion pore expansion [46,47]. Additionally, dynamin has been impli-
cated in the regulation of the actin cytoskeleton [48], which could ac-
count for the stronger negative effect of dynasore preincubation of
cells on NDV activities. The drug might negatively affect not only
endocytic entry but also the direct fusion of NDVwith the cell plasma
membrane. In sum, the data regarding the effect of dynasore on NDV
fusion and infectivity discussed above indicate that, at least in HeLa
and ELL-0 cells, NDV needs dynamin activity, as described for other
viruses such as HIV [14], HPV16 and BPV1 [49].
To prevent endosome acidiﬁcation, cells were incubated with either
concanamycin A, an inhibitor of vacuolar H+-ATPase [50], monensin,
an ionophore that disrupts the proton gradient across vesicular mem-
branes [51], or chloroquine, a lysosomotropic agent that increases pH
inside endocytic vesicles [52]. The concentration and drug treatment
times are speciﬁed in Table 1. Because of the high toxicity exerted by
the incubation of CHO and Lec1 cells with the three drugs, these exper-
iments were performed in HeLa, ELL-0, MEB4 and GM95 cell lines,
where treatment did not interfere with cell viability (cell viability was
about 95% or higher, data not shown). The data concerning the effect
of the three different compounds on NDV activities are summarized
in Fig. 7 and in Table 2. The treatment of cells with one of the three
compounds strongly inhibited virus–cell fusion, resulting in an approx-
imately 80% reduction in virus–cell fusion after concanamycin A and
monensin treatments, whereas chloroquine preincubation reduced
viral fusion by about 60% (Fig. 7A). Similarly, the three drugs strongly
reduced NDV infectivity (Fig. 7B, C, D). The negative effect of chloro-
quine was not observed if the drug was withdrawn when the virus
was added (Fig. 7C, CQ 1 h) or was added at 5 h post-infection
(Fig. 7C, CQ post-infection), meaning that the negative effect would
be exerted at the early steps of the viral cycle. Viral binding to the cell
surfacewas unaffected by any of the three compounds (Table 2). Never-
theless, in ELL-0 andHeLa cells fusion and infectivity inhibition by inhib-
itors of endosomal acidiﬁcation (Fig. 7 and Table 2) were stronger than
the enhancement observed after acid-pH treatment (Figs. 1 and 3). In
HeLa and ELL-0 cells, inhibition of virus infectivity resulting from
monensin treatment was largely prevented by exposure to acidic pH
(Supplementary Fig. S3). Moreover, concanamycin A, monensin and
chloroquine would interfere with processes other than NDV fusion in
endosomal compartments. In addition to raising the endosomal pH, it
has been reported that chloroquine has multiple effects on mammalian
cells [53]. Chloroquine inhibition of SARS-CoV infection is proposed to
be exerted due to the interference with the terminal glycosylation of
the viral receptor [54]. In addition, trafﬁcking events other than NDV
entry itself might be disturbed, since vesicular ATPase is involved in
the regulation of trafﬁcking events in endosomal compartments.
As an alternative assay of endocytic internalization, we realized
proteinase K protection experiments as detailed in Materials and
methods. Uninternalized virions as well as cell surface glycoproteins
from virions that have fused directly with the plasma membrane
would be digested by proteinase K, contrary to endocytosed virions
that became protected from digestion. In ELL-0 cells a signiﬁcant pro-
portion of HN glycoprotein became protected after 6 min of incubation
at 37 °C (Fig. 8A),which correlateswith use of an endocytic pathway for
virus entry. We also carried out the experiments with HeLa and MEB4
cells (Fig. 8B) looking for HN protection at 10 min after the initiation
of entry. Although total digestion of viral glycoproteins was not
observed at 4 °C (Fig. 8B, lanes 6 and 8), after incubation at 37 °C for
10 min we detected an increase in the proportion of non-digested
viral HN (Fig. 8B, lanes 5 and 7), strongly supporting that a percentage
of virus would also use endocytosis for entering both cell lines.
Class I viral fusion proteins can be activated by at least three different
triggers: low pH, receptor binding at neutral pH, or receptor binding
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Fig. 6.Effect of dynamin inhibition onNDVactivities. (A) Effect onNDV fusion.HeLa and ELL-0 cellswere previously incubated in the presenceof dynasore for 30 min at 37 °C. Then, 2 μg of
R18-NDVwas bound to cells for 30 min at 4 °C, after which these were allowed to fuse for 1 h at 37 °C in continuous presence of the drug. Fusion was quantiﬁed as detailed in Materials
andmethods as the percentage of red-stained cells out of the total. (B) Effect on NDV infectivity. HeLa and ELL-0 cells were previously incubated in the presence of dynasore for 30 min at
37 °C and then infected for 1 h at 37 °C in the presence of the inhibitorwith rNDV-F3aa-mRFP at amoi of 0.1 (HeLa) or 1 (ELL-0) to afford approximately 50% of cells infected in untreated
control cells. Dynasore was present in the culture medium for an additional 2 h before washing and incubation over a total of 24 h. Quantiﬁcation of infectivity was performed as in the
legend in Fig. 3. (C) After treatment of cells with 80 μMof dynasore, cells were infectedwith NDV “Clone 30” at amoi of 1. At 24 h post-infection, infectivity was analyzed by a FACS-based
immunoassay, as detailed in Materials and methods. Data are percentage of G mean ﬂuorescence values from those of control untreated and infected cells taken as 100%. (D) Effect of
the time of dynasore addition on NDV infectivity. Cells were infected with rNDV-F3aa-mRFP (moi of 0.1 and 1 for HeLa and ELL-0 cells respectively), and dynasore was added at different
times post-infection and was present in the culture medium for additional 2 h. Infection was determined as described above for (B). Data are means ± SD of three independent
experiments. **, p b 0.01, highly statistically signiﬁcant; ***, p b 0.001, extremely signiﬁcant.
307L. Sánchez-Felipe et al. / Biochimica et Biophysica Acta 1838 (2014) 300–309followed by low pH [55,56]. Moreover, the fusion protein of the human
metapneumovirus is activated by proteolysis and by acidic pH [20,25].
The use of the endocytic pathways for paramyxovirus entry has been sug-
gested as a common entry mechanism for the Pneumovirinae subfamily0
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fectivity. (A) Effect onNDV fusion. Cells were incubated for 1 h and 30 min in the presence
ells for 30 min at 4 °C and fusionwas allowed to proceed in the continuous presence of the
Cells were incubated for 1 h and 30 min in the presence of ConcA or monensin and then
were present in the culture medium for an additional 4 h before washing and incubation
DV infectivity. Cellswere infectedwith rNDV-F3aa-mRFP at amoi of 1, except for HeLa cells
rug 1 h before infection; CQ: cells preincubated with the drug 1 h before infection and for
then incubated for additional 6 h in the presence of the drug. At 24 h post-infection, NDV
monensin or CQ as in A, cells were infected with NDV “Clone 30” at a moi of 1. At 24 h
s and methods. Data are percentage of G mean ﬂuorescence values from those of control
periments. * p b 0.05 statistically signiﬁcant: ** p b 0.01 very signiﬁcant; ***, p b 0.001,
Table 2
Summary of the effect of drugs that interfere with endosome acidiﬁcation on NDV
interaction with different cell lines.
Cell Line
HeLa ELL-0 MEB4 GM95
ConcA Fusiona 19.3 ± 3.3 16.3 ± 6 21 ± 7 20.8 ± 2.2
Infectivitya 18.5 ± 7 24.5 ± 3.7 25.3 ± 6.5 9.4 ± 2
FACSb 13 ± 8 23 ± 8 21.6 ± 12 20 ± 5.2
Binding 100 100 100 100
Monensin Fusiona 20.4 ± 5 20.7 ± 4.2 13.2 ± 6 31.8 ± 4.4
Infectivitya 20.1 ± 4.1 20.6 ± 4.3 17.6 ± 5 20.1 ± 2.4
FACSb 7.5 ± 4 25.1 ± 11 12.1 ± 5 15.1 ± 3.2
Binding 100 100 100 100
Chloroquine Fusiona 37.5 ± 5.6 38.3 ± 7.5 30 ± 5 34.7 ± 7
Infectivitya 7 ± 0.8 52.6 ± 6 48.3 ± 1.6 47.1 ± 4
FACSb 35.7 ± 4 40 ± 10 34.6 ± 8
Binding 100 100 100 100
a Data are from Fig. 7, representing percentage of activity for control untreated cells.
b FACS infectivity assays, data from Fig. 7D
308 L. Sánchez-Felipe et al. / Biochimica et Biophysica Acta 1838 (2014) 300–309Although acid pH is not an absolute requirement for NDV infection, an
acid pH environmentwould facilitate the conformational changes needed
for fusionbydecreasing the energetic barrier, as suggested above. This hy-
pothetical decrease would not be enough for the activation of F in the ab-
sence of the homotypicHN (Fig. 2B), a phenotype thatwehave previously
observed inN211A, I463A and I463F protein Fmutants [57]. Another pos-
sibility is that acid pHwould increase the fusion promotion activity of HN
protein. As mentioned above, the second HN binding site, site II, is activa-
ted upon receptor binding to site I and exhibits higher receptor avidity
than site I [5]. As speculated for the paramyxovirus HPIV3 [58], low
pH may facilitate the exposure of site II and thus increase the fusion
promotion activity of the protein since site II has been shown to be
essential in HPIV3 and NDV F activation [59,60].
Within the context of an in vivo infection, i.e., without lowering the
pH experimentally, NDVwould be able to fuse at neutral and acidic pH,
depending on the entry pathways. In a cell-type-dependent mecha-
nism, a certain percentage of viruses might be endocytosed and hence
would fuse within the endosome. Similarly, some viruses utilize dif-
ferent cellular entry pathways to infect different target cells, such
as herpes simplex virus type 1 (HSV-1), which can enter cells through
theplasmamembrane aswell as by low-pH and neutral-pH endocytosis,
depending on the cell line and receptor(s) [19,34,61]. Also, vaccinia virusNot treated Proteinase K treated
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Fig. 8. Protection of viral HN glycoprotein from proteinase K digestion. (A). Virus was
attached to ELL-0 cells for 1 h at 4 °C. Entry was initiated by incubation at 37 °C for the
indicated times. Cells were treated with proteinase K, lysed, and viral HN protein was
detected byWestern blottingwith polyclonal anti-NDV antibodies. (B) Viruswas attached
to MEB4 (lanes 1, 2, 5, and 6) and HeLa (lanes 3, 4, 7, and 8) cells for 1 h at 4 °C. Samples
were then incubated at 37 °C for 10 min (lanes 1, 3, 5, and 7) or held at 4 °C (lanes 2, 4, 6,
and 8), treated with proteinase K for 1 h at 4 °C, and lysed as detailed in Materials and
methods. NDV-HN protein was detected by Western blotting.can simultaneously use both entry mechanisms in the same cell type:
fusion at the plasma membrane and endocytosis [62].
Concanamycin A,monensin and chloroquine strongly inhibited NDV
fusion and infectivity in MEB4 and GM95 cells (Fig. 7), although we
failed to observe any effect of the inhibitor BIM (Fig. 5) or any increase
in NDV activation after low-pH exposure in these cell lines (Figs. 1
and 3). This discrepancy may be explained by different possibilities:
i) NDV does not enterMEB4 nor GM95 by endocytosis, and the negative
effect of raising the pH in endosomes would be related to the interfer-
ence with trafﬁcking events other than NDV entry itself as discussed
above; ii) the endocytic entry of NDV into MEB4 (with GM3 as
the only ganglioside at the cell membrane) and GM95 (without
gangliosides) cells may follow a different mechanism from that of
HeLa and ELL-0 cells. Contrary to ELL-0 and HeLa cells, inhibition of
virus infectivity resulting from monensin treatment was not prevented
by exposure to acidic pH (Supplementary Fig. S3) supporting that the
inhibition of endosomal acidiﬁcation would have additional post-
entry effects in these cell lines. Nevertheless, further experiments will
be conducted to test these hypotheses.
The cell lines used in this study differ in the sialoglycoconjugates
present at the cell surface. ELL-0 andHeLa cellmembranes are abundant
in α2,6 sialic acid compounds in comparison with the other cell lines
([63] and data not shown). Thus, it is tempting to speculate that this
difference might be involved in diverse entry mechanisms of NDV into
the host cell: only when the virus engages the proper molecule could
be endocytosed, after which the viral envelope would fuse in the
endocytic compartments. The binding of NDV to sialic acids in α2,6
speciﬁc linkages could allow the endocytic entry of NDV, and could
be directly required either for endocytic internalization or to facilitate
subsequent molecular changes enabling endocytosis. Further experi-
ments will be needed to clarify this point.
Our data then support the notion that NDV might have evolved to
use the low pH of the endocytic pathways to enhance its entry, at
least in certain cell lines. In addition to direct fusion of the viral envelope
with the target cell, a certain percentage of viruses might penetrate the
cell through receptor-mediated and dynamin-dependent endocytosis.
This entry versatilitymust be taken into consideration in order to design
future antiviral strategies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2013.08.008.
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